Keyphrases
Liraglutide
100%
Metabolic Effects
100%
Diabetic Mice
100%
Neuroprotective Effect
100%
Dapagliflozin
100%
Insulin Sensitivity
22%
Energy Intake
22%
Insulin Concentration
22%
Glucose Concentration
22%
Glucose Tolerance
22%
Triglycerides
11%
Metabolic
11%
Sensitivity Analysis
11%
Glucagon
11%
Clinical Evaluation
11%
Hemoglobin A1c (HbA1c)
11%
Treatment Group
11%
Postsynaptic Density Protein 95 (PSD-95)
11%
Diabetes Management
11%
Once-daily
11%
Dentate Gyrus
11%
Densitometry
11%
Cell Area
11%
Novel Object Recognition
11%
High-fat Diet
11%
Glucagon-like peptide-1 (GLP-1)
11%
Once-daily Administration
11%
Insulin Content
11%
Fat Mass
11%
Streptozotocin
11%
Islet
11%
Recognition Memory
11%
Monotherapy
11%
Diet-induced
11%
Biochemical Analysis
11%
Neurodegenerative Diseases
11%
Dual-energy X-ray Absorptiometry
11%
IL-6 Level
11%
Corticosterone
11%
Alpha Cell
11%
Personalized Approach
11%
Neuroprotective Action
11%
Immature Neurons
11%
Synaptophysin
11%
Combination Therapy
11%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
11%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Diabetes Mellitus
100%
Liraglutide
100%
Neuroprotective Agent
100%
Dapagliflozin
100%
Insulin
55%
Glucose
44%
Fat
22%
Diseases
11%
Triacylglycerol
11%
Clinical Trial
11%
Hormone
11%
Glucagon-Like Peptide-1
11%
Glucagon
11%
Streptozotocin
11%
Hemoglobin A1c
11%
Monotherapy
11%
Glucagon Like Peptide 1 Receptor Agonist
11%
Combination Therapy
11%
Corticosterone
11%
Doublecortin
11%
Synaptophysin
11%
Sodium Glucose Cotransporter 2 Inhibitor
11%
Agricultural and Biological Sciences
Neuroprotective Effect
100%
Densitometry
12%
Recognition Memory
12%
Veterinary Science and Veterinary Medicine
Liraglutide
100%
Dentate Gyrus
12%
Medicine and Dentistry
Brain Histology
22%
Stratum Pyramidale
11%
Densitometry
11%
Stratum Oriens
11%
Neurodegenerative Disorder
11%
Absorptiometry
11%